A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 9/52 (2006.01) A61K 39/00 (2006.01) A61K 39/12 (2006.01) A61K 48/00 (2006.01) C07K 14/08 (2006.01) A61K 9/00 (2006.01)
Patent
CA 2209815
A vaccine protocol for inducing long-lasting cytotoxic T Iymphocyte (CTL) responses against specific antigen in humans involves use of a controlled release osmotic pump implant. Controlled release drives specific activation of CTL, facilitating continuous recirulation with potent cytotoxic activity for duration of implant.
Un protocole de vaccination pour induire des réponses durables des lymphocytotoxines (CTL) dirigées contre des antigènes spécifiques chez les humains met en jeu l'utilisation d'un implant qui est une pompe osmotique à libération contrôlée. La libération contrôlée commande une activation spécifique des CTL, facilitant la recirculation continue de l'activité cytotoxique efficace pendant la durée de vie de l'implant.
No affiliations
Bereskin & Parr
Haffner Andreas
Koch Frauke
Kundig Thomas
Millennium International Capital Investments Inc.
LandOfFree
Vaccine method using osmotic pump does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vaccine method using osmotic pump, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccine method using osmotic pump will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1786119